Mice infected with lactate dehydrogenase-elevating virus (LDV) were found to produce high titres of IgG anti-LDV antibodies that remained elevated for more than l year. This response, which was T-dependent, showed a striking preponderance of IgG2a with, from one strain to another, variable proportions of IgG2b and IgG3 but always very little IgG1. The binding of these antibodies to viral protein blots showed a major reaction with VP3, the heterogeneous glycosylated material of the viral envelope. A minor reaction was also noted with VPI, the nucleocapsid protein, but no antibodies were detected against VP2, the non-glycosylated envelope protein of LDV. A similar preponderance of anti-VP3 antibodies was also observed in a large set of anti-LDV hybridomas. Analysis of VP3 with monoclonal antibodies suggested that, despite its heterogeneity, this material has a common polypeptide moiety that apparently carries two major epitopes.
INTRODUCTION
Lactate dehydrogenase-elevating virus (LDV) is a mouse virus, related to the togavirus family, that induces a life-long viraemia and considerable immunological alterations in adult mice (Riley et al., 1960; Notkins et al., 1966b; Howard et al., 1969; Michaelides & Simms, 1980; Coutelier & Van Snick, 1985) . Infected mice have been found to produce significant amounts of anti-LDV antibodies, which form circulating immune complexes with the virus (Notkins et al., 1966a; Cafruny & Plagemann, 1982; McDonald et al., 1983) . Both the kinetics and the neutralizing activity of these antibodies have been studied extensively (Notkins et al., 1966a; Rowson et al., 1966; Porter et al., 1969) , but so far nothing is known about their specificity and their isotypic pattern has been elucidated only partially (McDonald et al., 1983) .
In the present report, we systematically examined the kinetics, T-dependence and isotypic distribution of anti-LDV antibodies in infected mice and investigated their specificity by Western blotting. Our data indicated that VP3, the glycosylated envelope protein (Michaelides & Schlesinger, 1973; Brinton-Darnell & Plagemann, 1975) , represented the major immunogenic structure of the virus. These results were confirmed and extended with a panel of monoclonal antibodies (MAb) . METHODS Mice. CBA/Ca mice were purchased from lffa Credo (Les Oncins, L'Arbresle, France) and 129/Sv, BALB/c, BALB/c nu/nu, CBA/Rij and C57BL/6 mice were bred by Dr G. Warnier at our Institute. NMRI mice were obtained from a local supplier.
Virus. LDV, Riley strain, was obtained from the American Type Culture Collection. Virus was isolated from 0000-6858 © 1986 SGM J'P. COUTELIER AND OTHERS NMRI mouse plasma collected 24 h post-infection. Purification was pcrformod either by isopycnic centrifugation as described by Brinton-Darnell & Plagemann (1975) or by velocity sedimentation in 5 to 20% sucrose gradients at 35000 r.p.m, for 105 min in a SW40 rotor (Beckman). Elution of the virus was followed at 256 nm in a u.v. monitor (Isco). After isopycnic centrifugation, the virus eluted as a narrow peak with a buoyant density of 1.13. Material of the same density was collected from the plasma of uninfected mice and was used as a mock-LDV. Nucleocapsid was isolated from purified virus by an additional centrifugation in the presence of 0.2% NP40 (Fluka, Buchs, Switzerland) as described by Michaelides & Schlesinger (1973) . The purity of this preparation was checked by SDS-PAGE.
The virus used for immunization was exposed for 90 rain to a 30 W u.v. lamp (Philips) at a distance of 15 cm. LDV titres were determined according to Rowson & Mahy (1975) and protein concentrations were estimated with a Bio-Rad protein assay kit.
LDVoxidation. After suspension in acetate buffer (0.l M, pH 4-5), purified LDV was incubated for 3 h at 20 °C with 3 mM-sodium metaperiodate. The reaction was stopped by the addition of glycerol (10 mM), followed by sodium borohydride (3 raM).
Enzyme-linked immunosorbent assays (ELISA).
Anti-LDV IgM and IgG were assayed by ELISA in polystyrene plates (no. 655101 ; Greiner, Nfirtingen, F.R.G.) coated overnight with LDV purified by isopycnic sedimentation (approx. 109 IDs0/ml or 0.7 gg/ml in 0.02 M-glycine, 0.03 M-NaC1, pH 9.2). Coated plates were incubated for 2 to 4 h with serial dilutions of sera in Tris-buffered saline (10 mM-Tris, 10 mM-merthiolate, 130 mM-NaC1, pH 7.4) containing 5% foetal bovine serum. After washing for 7 rain in saline containing 1% NP40, binding of IgG and IgM was measured with rabbit anti-mouse IgG or IgM antibodies labelled with peroxidase. Antibody concentrations were evaluated with reference to standard curves of IgG2a and IgM MAb specific for VP3. Nonspecific binding, including that of rabbit antibodies to LDV-coated plates and that of sera to wells coated with bovine serum albumin (BSA), was subtracted.
IgG antibody isotypes were determined by developing the ELISA with rabbit antibodies specific for each mouse IgG subclass followed by peroxidase-conjugated goat anti-rabbit IgG antibodies. The non-specific binding of rabbit antibodies to wells coated with our LDV preparations did not exceed 10% of the values observed for positive sera. It was nevertheless subtracted from the tests. C57BL/6 IgG2a was measured with an allotypespecific MAb of BALB/c origin. Subclass-specific assays were calibrated with reference to standard curves of purified anti-dinitrophenyl (DNP) MAb of equivalent affinity to wells coated with dinitrophenylated BSA (DNPt3-BSA, 10 ~tg/ml; a gift from DrG. V. Gulaf of our laboratory). The specificity of these assays is shown in Fig. 1 . A wide range of threefold dilutions was examined in duplicate for each serum. When interpolated on the corresponding standard curve, three or more dilutions usually gave linear results, which were then averaged to calculate the antibody concentration. Non-specific binding of sera from infected mice to BSA-coated plates or of normal sera to LDV-coated wells did not exceed 3% of the positive values.
All the immunological reagents used for the ELISA assays were produced in our laboratory.
Preparation ofMAb. Anti-LDV MAb were derived from three groups of animals: (i) mice infected as described previously (Coutelier & Van Snick, 1985) , (ii) mice that received four weekly subcutaneous injections of approx. 50 ~tg u.v.-treated purified LDV in complete Freund's adjuvant (CFA) and (iii) mice immunized by three injections, at 2 week intervals, of an equivalent amount of LDV nucleocapsid emulsified in CFA. Immunized mice were boosted 4 days before fusion was performed. Hybridizations were carried out with SP2/O-Ag-14 cells (Shulman et al., 1978) by conventional procedures.
Anti-LDV MAb were detected and immunoglobulin isotypes were determined as described by Coutelier & Van Snick (1985) . IgG proteins were isolated from ascites by affinity chromatography on Protein A-Sepharose (Pharmacia) (Ey et al., 1978) and IgM was purified by gel filtration on AcA22 (LKB).
Eleetrophoresis ofLD Vproteins and silver staining. Viral proteins were separated by electrophoresis in 10 to 15 % gradient polyacrylamide gels (acrylamide 97.7%, Merck; N,N'-methylenebisacrylamide 2.3%, Koch-Light) as described by Laemmli (1970) and stained with silver nitrate according to Morrissey (1981) . Mol. wt. standards were purchased from Pharmacia.
Immunoblotting. After electrophoretic separation, viral proteins were transferred onto nitrocellulose sheets (0.45 pro; BA 85, Schleicher & Schiill) at 60 V for 2 h (Towbin et al., 1979) . Transfer was checked by staining with colloidal gold (AuroDye, Janssen Pharmaceutica Life Sciences Products, Beerse, Belgium), according to the manufacturer's recommendations. Strips of nitrocellulose were blocked with Tris-buffered saline (0.01 M-Tris-HCI, 0.15 M-NaC1, pH 7.4) containing 3% BSA and incubated overnight with antibodies diluted in the same buffer. After extensive washing, bound antibodies were detected with peroxidase-conjugated goat anti-mouse Ig and 4-chloro-l-naphthol (0.5 mg/ml in Tris-buffered saline containing 20% methanol and 0.015% H202).
As a source of serum antibodies, we used an Ig-enriched fraction obtained by precipitation with 50% ammonium sulphate.
Isoelectric focusing (IEF)
. This was performed following conventional procedures as reported previously (Coutelier & Van Snick, 1985) . 
RESULTS

Structural proteins of LD V grown in vivo
LDV was isolated by isopycnic or velocity centrifugation from the plasma of acutely infected mice. Silver-stained SDS-polyacrylamide gels of these preparations revealed the existence of five polypeptide bands that were not present in mock-LDV (Fig. 2) . Three bands corresponded approximately to VPI, VP2 and VP3, the three polypeptides that have been described for radiolabelled virus grown in vitro (Michaelides & Schlesinger, 1973; Brinton-Darnell & Plagemann, 1975) . However, in our preparations, the envelope protein designated VP2 had an apparent tool. wt. of 21K rather than 17K as reported for virus grown in vitro and the heterogeneous material described as VP3 was found to consist of several discrete bands migrating between 27K and 38K. The two other bands that were not seen in mock-LDV had apparent tool. wt. of 25K and 70K.
LDV prepared by isopycnic centrifugation contained several bands that were almost completely absent from the virus isolated by velocity sedimentation. These bands were also observed in material purified from uninfected mice, suggesting that they corresponded to serum contaminants (Fig. 2) .
Kinetics and specificity of the anti-LDV antibody response
Both IgM and IgG anti-LDV antibodies were measured in sera collected at different times post-infection. As described previously (Porter et al., 1969; Cafruny & Plagemann, 1982) , a slight antiviral response could be detected in some mice as soon as 6 days after LDV inoculation (data not shown) but as a rule it was not before 2 weeks post-infection that all mice developed significant antibody titres. Unlike IgM antibodies, which peaked about 1 month after infection, IgG antibody titres increased steadily for about 2 months and remained elevated for more than 1 year (Fig. 3) . 
VP3
• at VP2 VP1 Fig. 2 . Silver-stained SDS-polyacrylamide gel of mock-LDV (lane 1) and of LDV prepared by isopycnic and velocity centrifugation (lanes 2 and 3, respectively). Mol. wt. are indicated x 10 -3. LDV samples contained approx. 5 pg protein.
The specificity of anti-LDV antibodies was tested on viral protein blots. In sera collected 1 to 2 months post-infection, most antibodies were found to react with VP3. A minor reaction was also observed with VP1 but no anti-VP2 antibodies could be detected even though the three major proteins of the virus were effectively transferred to the nitrocellulose sheets (Fig. 4) . Analysis of sera collected at earlier stages of infection showed that antibodies reacting with VP1 appeared slightly before anti-VP3 antibodies. The same specificity patterns were observed in four different mouse strains, namely 129/Sv, BALB/c, C57BL/6 and CBA/Rij. The anti-LDV specificity of these reactions was ascertained by testing infected sera on a mock-LDV preparation (data not shown).
To test for a possible relation between antibody specificity and isotype, we separated IgG subclasses from pooled sera of chronically infected 129/Sv mice by sequential elution from Protein A-Sepharose as described by Ey et al. (1978) . Irrespective of their isotypic profile (see Table 1 ), the resulting fractions showed the same reactivity pattern with LDV proteins as the one depicted for unfractionated antibodies in Fig. 4 (data not shown) . 
Isotypie distribution of anti-LD V antibodies
The isotypic distribution of anti-LDV antibodies was tested by ELISA in four different mouse strains. The overall pattern varied little with time. In CBA/Rij, BALB/c and 129/Sv mice, most anti-LDV antibodies were IgG2a (58 ~o to 86 ~ of all IgG anti-LDV antibodies). In the C57BL/6 strain, IgG2a, IgG2b and IgG3 accounted for approximately the same proportion of the anti-LDV activity with, in contrast to the other strains, important variations from one animal to another (Table 2) . Surprisingly, the proportion of IgG 1 anti-LDV antibodies always remained extremely low, irrespective of the strain of mice or of the time elapsed since the infection.
T-dependence of the anti-LD V antibody response
Analysis of anti-LDV response in BALB/c nude mice indicated that, as described for other viruses by Burns et al. (1975) , the production of antibodies against LDV was essentially a Tdependent phenomenon (Table 3) . In Western blots, anti-VP3 antibodies were completely absent and only a minor reaction against VP1 could still be observed (data not shown).
Monoclonal anti-LD V antibodies
To characterize the specificity of the anti-LDV response further, hybridomas were derived at different times after infection. As the number of anti-LDV MAb obtained after a natural infection was rather low, hybridomas were also derived after immunization with whole u.v.-treated LDV emulsified in CFA. Although live viruses could persist in this preparation, this procedure yielded a large number of anti-LDV MAb (Table 4) . Hybrids were also derived after immunization with purified nucleocapsid. Several of these MAb were subcloned and tested by IEF to ascertain their clonal nature (Fig. 5) .
In Western blots, all the clones obtained from infected animals or from the mice immunized with u.v.-treated virus reacted with VP3. On the basis of their reactivity pattern, two sets of anti-VP3 antibodies could be identified. Most of them (61 of 77 tested) reacted only with the heterogeneous material migrating between 27K and 38K while the remaining 16 recognized also the 25K band observed in the silver-stained gels. As expected, antibodies obtained after immunization with purified nucleocapsid were specific for VP1 (Fig. 6) .
To examine the nature of the antigenic determinants of VP3, LDV was oxidized with sodium metaperiodate. This treatment completely abolished the reaction of concanavalin A with VP3, indicating that the protein was effectively deglycosylated (Fig. 7) . In contrast, the b i n d i n g of several anti-VP3 I g G 2 a M A b was not abolished under these conditions, suggesting that they reacted with the protein moiety a n d not with the carbohydrate residues of VP3. A typical result is shown in Fig. 7 . 
DISCUSSION
Western blot analysis has shown that the antiviral antibody response of mice infected with LDV is predominantly directed against VP3, the viral envelope glycoprotein. A minor response against VP 1, the nucleocapsid protein, could also be detected but no antibodies against VP2, the non-glycosylated envelope protein, could be observed. This absence of detectable anti-VP2 antibodies was probably not due to inefficient transfer or excessive denaturation of the protein during blotting. Staining of the blots with colloidal gold demonstrated that VP2 was correctly transferred to the nitrocellulose and preliminary results indicate that, in the serum of certain mice immunized with inactivated virus, antibodies against VP2 react with the transferred protein (data not shown). It seems likely therefore that the production of anti-VP2 antibodies in infected mice is, if anything, very low, a conclusion which is corroborated by our failure to obtain hybridomas with anti-VP2 activity. However, the possibility should be borne in mind that small amounts of circulating anti-VP2 antibodies could be further masked by in vivo absorption onto LDV, which is known to form immune complexes in the circulation of chronically infected mice (Notkins et al., 1966a; Cafruny & Plagemann, 1982; McDonald et al., 1983) .
McDonald et al. (1983) have shown that IgG2 antibodies prevail in the anti-LDV response of chronically infected mice. Using more specific reagents, we have found that, in most strains, IgG2a and not IgG2b represented the preponderant anti-LDV subclass. Moreover, we have observed that the contribution of IgG3 to the anti-LDV response, although more variable than that of IgG2a, was not negligible in certain mouse strains (BALB/c, C57BL/6). In contrast, we have not been able to confirm the observation reported by McDonald et al. that , in sera collected early after infection, IgG 1 was the prevailing anti-LDV antibody. The preponderance of IgG2a in the anti-LDV response contrasts with that of IgG 1 after immunization with conventional soluble protein antigens (Rosenberg & Chiller, 1979) . In this context, it would be of interest to determine whether the isotypic pattern observed here is a common characteristic of antiviral immune responses in the mouse.
Previous studies on the protein composition of LDV, which were performed with radioactively labelled virus grown in vitro, have shown that VP3 has a heterogeneous migration pattern (Michaelides & Schlesinger, 1973; Brinton-Darnell & Plagemann, 1975) . The staining obtained in our protein blots with each of 77 anti-VP3 MAb had the same heterogeneous appearance as that of VP3 in the silver-stained gels. Moreover, the 25K protein detected in silver-stained gels was recognized by a set of carefully cloned anti-VP3 MAb, indicating that this polypeptide belonged to the VP3 family. Oxidation of LDV with metaperiodate did not abolish the binding of the anti-VP3 MAb tested, suggesting that, within the limits of this technique, the anti-LDV response is at least partly directed against the protein moiety of VP3. Altogether, these findings strongly suggest that the different components of VP3 that were identified in SDS-PAGE share a common polypeptide structure.
On the basis of their reaction in Western blots, anti-VP3 MAb could be divided into two groups, suggesting the existence of two major epitopes. The higher mol. wt components of VP3, which migrated between 27K and 38K, reacted with both sets of MAb indicating that they carried both epitopes. By contrast, the 25K band which reacted with only one set of MAb seemed to express only one epitope. This could indicate that the smaller VP3 component lacks part of the amino acid sequences present in the VP3 polypeptides of higher mol. wt.
The availability of a large panel of MAb should make it possible to gain some insight into the mechanisms of LDV neutralization and also to examine the antigenic relationship between LDV and other viruses classified in the togavirus family.
